Uniqure Notches Bullish Initiation On Gene Therapy Prospects By: Benzinga via Benzinga May 20, 2018 at 16:38 PM EDT Uniqure NV (NASDAQ: QURE) has managed to win the seal of approval from Wells Fargo Securities due to its gene therapy pipeline ... Read More >> Related Stocks: Bristol-Myers Squibb Ionis Pharmaceuticals Roche Holding AG Basel American Depositary Shares Uniqure Ord Shs